The suppression of TNF production in diseases such as rheumatoid arthritis (RA), which requires anti-TNF treatment, disrupts this equilibrium, leading to the inhibition of DC maturation and the production of excessive amounts of IFN-α/β [68,69]. The gene discussed is IFNA1; the disease is rheumatoid arthritis.